MelCher5k/<i>BRAF</i><sup>+</sup> subcutaneous human melanoma xenograft with CD20 expression

MelCher5k/<i>BRAF</i><sup>+</sup> subcutaneous human melanoma xenograft with CD20 expression

Introduction. Metastatic melanoma of the skin (mMC) is characterized by an extremely unfavorable prognosis of survival. Significant remission of mMK is associated with the use of vemurafenib, which blocks the proliferation of cells with a mutation in the BRAF gene. However, after its cancellation, r...

Full description

Saved in:
Bibliographic Details
Main Authors: I. N. Mikhaylova, H. M. Treshalina, S. Sh. Karshieva, D. A. Khochenkov, N. V. Andronova, I. Zh. Shubina, M. V. Kiselevskiy
Format: Article
Language:Russian
Published: ABV-press 2025-06-01
Series:Успехи молекулярной онкологии
Subjects:
<i>braf</i><sup>+</sup> human melanoma xenograft
vemurafenib
remission
cd20
Online Access:https://umo.abvpress.ru/jour/article/view/786
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items